The developmental environment and atherogenesis

C. Napoli, O. Pignalosa, L. Rossi, C. Botti, C. Guarino, V. Sica, F. de Nigris

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Introduction Crucial advances in our understanding of atherogenesis have been achieved during the past two decades. The historical hypothesis of pathogenesis (‘lipid accumulation’) has evolved to integrate several pathogenic mechanisms contributing to the initiation and evolution of atherogenesis. Vascular inflammation and apoptosis may play pivotal roles in its progression and onset. Endothelial dysfunction is considered to be one of the earliest events in atherogenesis. This chapter will discuss emerging concepts in the pathogenesis of, and therapeutic approaches to, atherosclerosis. Some novel risk factors, including impaired fasting glucose, triglycerides and triglyceride-rich lipoprotein remnants, lipoprotein (a), homocysteine, and high-sensitivity C-reactive protein, might contribute to an increased risk of atherosclerosis (Fruchart et al. 2004). Moreover, hypercholesterolaemia and hypertension have synergistic deleterious effects on coronary endothelial function (Rodriguez-Porcel et al. 2003). The pathogenesis of atherosclerosis has been related also to infiltration of immune cells, which are involved in systemic and local, innate as well as adaptive, immune responses (Zhou and Hansson 2004). As some inflammatory and autoimmune diseases could be treated by immunologically based therapy, it is of particular interest to consider whether such principles could also be applied to prevent or treat atherosclerosis. Atherosclerosis is ultimately responsible for myocardial infarction, peripheral arterial disease and ischaemic stroke, and is characterised by a long lag-time between onset and clinical manifestation. The prodromal stages of human atherosclerotic lesions are already formed during fetal development (Napoli et al. 1997a, 1999a, Palinski and Napoli 2002a). Intimal thickening is also observed in fetal coronary arteries (Ikari et al. 1999).

Original languageEnglish
Title of host publicationDevelopmental Origins of Health and Disease
PublisherCambridge University Press
Pages300-309
Number of pages10
ISBN (Print)9780511544699, 0521847435, 9780521847438
DOIs
Publication statusPublished - Jan 1 2006

Fingerprint

Atherosclerosis
Triglycerides
Tunica Intima
Prodromal Symptoms
Lipoprotein(a)
Peripheral Arterial Disease
Adaptive Immunity
Homocysteine
Fetal Development
Hypercholesterolemia
C-Reactive Protein
Autoimmune Diseases
Lipoproteins
Blood Vessels
Fasting
Coronary Vessels
Stroke
Myocardial Infarction
Apoptosis
Hypertension

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Napoli, C., Pignalosa, O., Rossi, L., Botti, C., Guarino, C., Sica, V., & de Nigris, F. (2006). The developmental environment and atherogenesis. In Developmental Origins of Health and Disease (pp. 300-309). Cambridge University Press. https://doi.org/10.1017/CBO9780511544699.023

The developmental environment and atherogenesis. / Napoli, C.; Pignalosa, O.; Rossi, L.; Botti, C.; Guarino, C.; Sica, V.; de Nigris, F.

Developmental Origins of Health and Disease. Cambridge University Press, 2006. p. 300-309.

Research output: Chapter in Book/Report/Conference proceedingChapter

Napoli, C, Pignalosa, O, Rossi, L, Botti, C, Guarino, C, Sica, V & de Nigris, F 2006, The developmental environment and atherogenesis. in Developmental Origins of Health and Disease. Cambridge University Press, pp. 300-309. https://doi.org/10.1017/CBO9780511544699.023
Napoli C, Pignalosa O, Rossi L, Botti C, Guarino C, Sica V et al. The developmental environment and atherogenesis. In Developmental Origins of Health and Disease. Cambridge University Press. 2006. p. 300-309 https://doi.org/10.1017/CBO9780511544699.023
Napoli, C. ; Pignalosa, O. ; Rossi, L. ; Botti, C. ; Guarino, C. ; Sica, V. ; de Nigris, F. / The developmental environment and atherogenesis. Developmental Origins of Health and Disease. Cambridge University Press, 2006. pp. 300-309
@inbook{544599ebf1994a10a5f0933336f696e6,
title = "The developmental environment and atherogenesis",
abstract = "Introduction Crucial advances in our understanding of atherogenesis have been achieved during the past two decades. The historical hypothesis of pathogenesis (‘lipid accumulation’) has evolved to integrate several pathogenic mechanisms contributing to the initiation and evolution of atherogenesis. Vascular inflammation and apoptosis may play pivotal roles in its progression and onset. Endothelial dysfunction is considered to be one of the earliest events in atherogenesis. This chapter will discuss emerging concepts in the pathogenesis of, and therapeutic approaches to, atherosclerosis. Some novel risk factors, including impaired fasting glucose, triglycerides and triglyceride-rich lipoprotein remnants, lipoprotein (a), homocysteine, and high-sensitivity C-reactive protein, might contribute to an increased risk of atherosclerosis (Fruchart et al. 2004). Moreover, hypercholesterolaemia and hypertension have synergistic deleterious effects on coronary endothelial function (Rodriguez-Porcel et al. 2003). The pathogenesis of atherosclerosis has been related also to infiltration of immune cells, which are involved in systemic and local, innate as well as adaptive, immune responses (Zhou and Hansson 2004). As some inflammatory and autoimmune diseases could be treated by immunologically based therapy, it is of particular interest to consider whether such principles could also be applied to prevent or treat atherosclerosis. Atherosclerosis is ultimately responsible for myocardial infarction, peripheral arterial disease and ischaemic stroke, and is characterised by a long lag-time between onset and clinical manifestation. The prodromal stages of human atherosclerotic lesions are already formed during fetal development (Napoli et al. 1997a, 1999a, Palinski and Napoli 2002a). Intimal thickening is also observed in fetal coronary arteries (Ikari et al. 1999).",
author = "C. Napoli and O. Pignalosa and L. Rossi and C. Botti and C. Guarino and V. Sica and {de Nigris}, F.",
year = "2006",
month = "1",
day = "1",
doi = "10.1017/CBO9780511544699.023",
language = "English",
isbn = "9780511544699",
pages = "300--309",
booktitle = "Developmental Origins of Health and Disease",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - The developmental environment and atherogenesis

AU - Napoli, C.

AU - Pignalosa, O.

AU - Rossi, L.

AU - Botti, C.

AU - Guarino, C.

AU - Sica, V.

AU - de Nigris, F.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Introduction Crucial advances in our understanding of atherogenesis have been achieved during the past two decades. The historical hypothesis of pathogenesis (‘lipid accumulation’) has evolved to integrate several pathogenic mechanisms contributing to the initiation and evolution of atherogenesis. Vascular inflammation and apoptosis may play pivotal roles in its progression and onset. Endothelial dysfunction is considered to be one of the earliest events in atherogenesis. This chapter will discuss emerging concepts in the pathogenesis of, and therapeutic approaches to, atherosclerosis. Some novel risk factors, including impaired fasting glucose, triglycerides and triglyceride-rich lipoprotein remnants, lipoprotein (a), homocysteine, and high-sensitivity C-reactive protein, might contribute to an increased risk of atherosclerosis (Fruchart et al. 2004). Moreover, hypercholesterolaemia and hypertension have synergistic deleterious effects on coronary endothelial function (Rodriguez-Porcel et al. 2003). The pathogenesis of atherosclerosis has been related also to infiltration of immune cells, which are involved in systemic and local, innate as well as adaptive, immune responses (Zhou and Hansson 2004). As some inflammatory and autoimmune diseases could be treated by immunologically based therapy, it is of particular interest to consider whether such principles could also be applied to prevent or treat atherosclerosis. Atherosclerosis is ultimately responsible for myocardial infarction, peripheral arterial disease and ischaemic stroke, and is characterised by a long lag-time between onset and clinical manifestation. The prodromal stages of human atherosclerotic lesions are already formed during fetal development (Napoli et al. 1997a, 1999a, Palinski and Napoli 2002a). Intimal thickening is also observed in fetal coronary arteries (Ikari et al. 1999).

AB - Introduction Crucial advances in our understanding of atherogenesis have been achieved during the past two decades. The historical hypothesis of pathogenesis (‘lipid accumulation’) has evolved to integrate several pathogenic mechanisms contributing to the initiation and evolution of atherogenesis. Vascular inflammation and apoptosis may play pivotal roles in its progression and onset. Endothelial dysfunction is considered to be one of the earliest events in atherogenesis. This chapter will discuss emerging concepts in the pathogenesis of, and therapeutic approaches to, atherosclerosis. Some novel risk factors, including impaired fasting glucose, triglycerides and triglyceride-rich lipoprotein remnants, lipoprotein (a), homocysteine, and high-sensitivity C-reactive protein, might contribute to an increased risk of atherosclerosis (Fruchart et al. 2004). Moreover, hypercholesterolaemia and hypertension have synergistic deleterious effects on coronary endothelial function (Rodriguez-Porcel et al. 2003). The pathogenesis of atherosclerosis has been related also to infiltration of immune cells, which are involved in systemic and local, innate as well as adaptive, immune responses (Zhou and Hansson 2004). As some inflammatory and autoimmune diseases could be treated by immunologically based therapy, it is of particular interest to consider whether such principles could also be applied to prevent or treat atherosclerosis. Atherosclerosis is ultimately responsible for myocardial infarction, peripheral arterial disease and ischaemic stroke, and is characterised by a long lag-time between onset and clinical manifestation. The prodromal stages of human atherosclerotic lesions are already formed during fetal development (Napoli et al. 1997a, 1999a, Palinski and Napoli 2002a). Intimal thickening is also observed in fetal coronary arteries (Ikari et al. 1999).

UR - http://www.scopus.com/inward/record.url?scp=84927085304&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927085304&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511544699.023

DO - 10.1017/CBO9780511544699.023

M3 - Chapter

SN - 9780511544699

SN - 0521847435

SN - 9780521847438

SP - 300

EP - 309

BT - Developmental Origins of Health and Disease

PB - Cambridge University Press

ER -